Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melinda S Yates

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Drug News & Perspectives|April 19, 2007
Chemopreventive promise of targeting the Nrf2 pathwayMelinda S Yates, Thomas W Kensler
Journal of Gynecologic Oncology|August 19, 2020
Pushing the envelope: expanding fertility sparing treatment of endometrial cancerKatherine Ikard Stewart, Melinda S Yates, Shannon N Westin
Cancer Prevention Research (Philadelphia, Pa.)|September 10, 2009
The monkey, the hen, and the mouse: models to advance ovarian cancer chemopreventionKaren H Lu, Melinda S Yates, Samuel C Mok
Cancer Prevention Research (Philadelphia, Pa.)|July 10, 2023
TIME for Bugs: The Immune Microenvironment and Microbes in PrecancerMikayla Borthwick Bowen, Beth A Helmink, Jennifer A Wargo, et al.
Gynecologic Oncology|December 13, 2023
Obesity is associated with improved progression-free survival in Microsatellite-Instability-High endometrial cancer treated with pembrolizumabLaurence Bernard, Jeffrey A How, Shrina Patel, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|June 22, 2016
Bringing Cancer Prevention Research Competencies to the ClassroomMelinda S Yates, Shine Chang, Hwa-Young Lee, et al.
Current Oncology Reports|October 3, 2024
Uterine-Conserving Treatment Options for Atypical Endometrial Hyperplasia and Early Endometrial CancerNaomi N Adjei, Mikayla Borthwick Bowen, Roni Nitecki Wilke, et al.
Oncology|December 9, 2016
Lean Body Weight and Metformin Are Insufficient to Prevent Endometrial Hyperplasia in Mice Harboring Inactivating Mutations in PTENDavid A Iglesias, Qian Zhang, Joseph Celestino, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 13, 2017
Endometrial Cancers With Activating KRas Mutations Have Activated Estrogen Signaling and Paradoxical Response to MEK InhibitionKari L Ring, Melinda S Yates, Rosemarie Schmandt, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 15, 2015
Salpingectomy as a means to reduce ovarian cancer riskMary B Daly, Charles W Dresher, Melinda S Yates, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Drug News & Perspectives|April 19, 2007
Chemopreventive promise of targeting the Nrf2 pathwayMelinda S Yates, Thomas W Kensler
Journal of Gynecologic Oncology|August 19, 2020
Pushing the envelope: expanding fertility sparing treatment of endometrial cancerKatherine Ikard Stewart, Melinda S Yates, Shannon N Westin
Cancer Prevention Research (Philadelphia, Pa.)|September 10, 2009
The monkey, the hen, and the mouse: models to advance ovarian cancer chemopreventionKaren H Lu, Melinda S Yates, Samuel C Mok
Cancer Prevention Research (Philadelphia, Pa.)|July 10, 2023
TIME for Bugs: The Immune Microenvironment and Microbes in PrecancerMikayla Borthwick Bowen, Beth A Helmink, Jennifer A Wargo, et al.
Gynecologic Oncology|December 13, 2023
Obesity is associated with improved progression-free survival in Microsatellite-Instability-High endometrial cancer treated with pembrolizumabLaurence Bernard, Jeffrey A How, Shrina Patel, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|June 22, 2016
Bringing Cancer Prevention Research Competencies to the ClassroomMelinda S Yates, Shine Chang, Hwa-Young Lee, et al.
Current Oncology Reports|October 3, 2024
Uterine-Conserving Treatment Options for Atypical Endometrial Hyperplasia and Early Endometrial CancerNaomi N Adjei, Mikayla Borthwick Bowen, Roni Nitecki Wilke, et al.
Oncology|December 9, 2016
Lean Body Weight and Metformin Are Insufficient to Prevent Endometrial Hyperplasia in Mice Harboring Inactivating Mutations in PTENDavid A Iglesias, Qian Zhang, Joseph Celestino, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 13, 2017
Endometrial Cancers With Activating KRas Mutations Have Activated Estrogen Signaling and Paradoxical Response to MEK InhibitionKari L Ring, Melinda S Yates, Rosemarie Schmandt, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 15, 2015
Salpingectomy as a means to reduce ovarian cancer riskMary B Daly, Charles W Dresher, Melinda S Yates, et al.
Pageof 5